Adam Reich Selected Research

Adam Reich Research Topics

Disease

37	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 01/2007
22	Pruritus (Itching) 10/2023 - 01/2005
8	Neoplasms (Cancer) 02/2024 - 12/2015
7	Atopic Dermatitis (Atopic Eczema) 10/2023 - 11/2008
5	Prurigo 05/2024 - 01/2020
5	Body Weight (Weight, Body) 11/2023 - 01/2011
5	Mycosis Fungoides 02/2017 - 11/2015
4	Infections 10/2023 - 02/2006
4	Inflammation (Inflammations) 10/2023 - 06/2020
4	Eczema 03/2023 - 11/2008
4	Skin Diseases (Skin Disease) 02/2017 - 04/2013
3	Acne Vulgaris 10/2022 - 06/2019
3	Cutaneous Lupus Erythematosus 10/2013 - 09/2006
2	Actinic Keratosis 11/2023 - 06/2023
2	Nausea 10/2023 - 09/2019
2	COVID-19 10/2023 - 01/2021
2	Headache (Headaches) 10/2023 - 01/2023
2	Urticaria (Hives) 10/2023 - 12/2022
2	Chronic Urticaria 10/2023 - 12/2022
2	Pyoderma Gangrenosum 08/2023 - 01/2023
2	Hidradenitis Suppurativa 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 06/2019
2	Mental Disorders (Mental Disorder) 01/2022 - 12/2019
2	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2015
2	Lichen Planus (Lichen Ruber Planus) 11/2015 - 01/2013
2	Onychomycosis (Tinea Unguium) 07/2009 - 10/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2024
1	Osteoporosis 02/2024
1	Psoriatic Arthritis 12/2023
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2023
1	Nasopharyngitis 10/2023
1	Pityriasis Rubra Pilaris 10/2023
1	Alopecia Areata 03/2023
1	Alopecia universalis 03/2023
1	Vitiligo 01/2022
1	Hyperhidrosis 01/2022

Drug/Important Bio-Agent (IBA)

6	secukinumabIBA 10/2023 - 12/2020
6	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 09/2023 - 10/2021
6	calcipotriene (calcipotriol)FDA LinkGeneric 09/2023 - 10/2021
5	Immunoglobulin A (IgA)IBA 10/2023 - 01/2017
5	Adalimumab (Humira)FDA Link 10/2023 - 02/2016
5	Infliximab (Remicade)FDA Link 08/2022 - 12/2020
5	AntipruriticsIBA 09/2019 - 01/2007
4	ixekizumabIBA 12/2023 - 12/2018
4	Ustekinumab (CNTO 1275)FDA Link 11/2023 - 12/2020
4	Monoclonal AntibodiesIBA 10/2023 - 10/2013
4	risankizumabIBA 10/2023 - 12/2020
4	InterleukinsIBA 09/2023 - 01/2007
4	Prostaglandins AIBA 09/2023 - 08/2017
4	NeuropeptidesIBA 10/2021 - 01/2007
4	LipidsIBA 01/2021 - 01/2005
3	nemolizumabIBA 05/2024 - 01/2020
3	EnzymesIBA 09/2023 - 02/2006
3	SuspensionsIBA 09/2023 - 03/2022
3	CytokinesIBA 09/2023 - 06/2004
3	Substance PIBA 10/2021 - 01/2007
3	Etanercept (Enbrel)FDA Link 01/2021 - 12/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 11/2008
3	EmollientsIBA 02/2020 - 06/2005
3	EndocannabinoidsIBA 01/2016 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2016
2	Biosimilar PharmaceuticalsIBA 11/2023 - 08/2022
2	apremilastIBA 10/2023 - 01/2016
2	remibrutinibIBA 10/2023 - 12/2022
2	Histamine Antagonists (Antihistamines)IBA 10/2023 - 10/2017
2	Interleukin-23 (Interleukin 23)IBA 09/2023 - 01/2022
2	Local Anti-Infective Agents (Antiseptics)IBA 01/2023 - 09/2005
2	AerosolsIBA 06/2022 - 10/2021
2	Calcitonin Gene-Related PeptideIBA 10/2021 - 05/2007
2	Serotonin (5 Hydroxytryptamine)IBA 10/2021 - 01/2007
2	Peptide Hydrolases (Proteases)FDA Link 10/2021 - 01/2007
2	SteroidsIBA 08/2021 - 05/2021
2	Acitretin FDA Link 01/2021 - 01/2021
2	AntigensIBA 04/2020 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2019 - 09/2005
2	Opioid Receptors (Opioid Receptor)IBA 05/2017 - 01/2012
2	CalciumIBA 11/2016 - 06/2004
2	CannabinoidsIBA 01/2016 - 01/2005
2	Opioid Analgesics (Opioids)IBA 01/2012 - 01/2007
2	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 05/2007 - 01/2007
2	Neuropeptide YIBA 05/2007 - 01/2007
1	Oxygen (Dioxygen)IBA 11/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2023
1	Photosensitizing Agents (Photosensitizers)IBA 11/2023
1	LigandsIBA 10/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023
1	upadacitinibIBA 03/2023
1	Janus Kinase InhibitorsIBA 03/2023
1	W 12IBA 11/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2022
1	Interleukin-12 (IL 12)IBA 01/2022

Therapy/Procedure

27	Therapeutics 10/2023 - 01/2005
3	Photochemotherapy (Photodynamic Therapy) 11/2023 - 06/2023
3	Immunotherapy 01/2022 - 06/2019
2	Contraindications 08/2022 - 01/2022
2	Conservative Treatment 11/2016 - 02/2015
2	Renal Dialysis (Hemodialysis) 01/2016 - 01/2005
1	Subcutaneous Injections 10/2023
1	Hematopoietic Stem Cell Transplantation 08/2023